InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,180.74
(
1.03%
)
US TECH 100
17,600.00
(
1.04%
)
Dow Jones
38,852.27
(
0.46%
)
Brent Oil
83.36
(
0.28%
)
Bitcoin
63,391.97
(
-0.95%
)
Post# of 251730
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 827
Posts 119579
Boards Moderated 14
Alias Born 09/05/2002

DewDiligence

Member Level

Re: dewophile post# 222778

Thursday, 12/13/2018 8:56:49 PM

Thursday, December 13, 2018 8:56:49 PM

Post# of 251730

ADXS—Amgn mentioned [ADXS-NEO] in a fairly recent investor presentation if memory serves…

It was actually a tweet from Jun 2018, shortly after the first NEO patient was dosed, so that doesn’t tell us much.

Of greater interest to me is the fact that ADXS’ CSO, Robert Petit, posted a positive comment about NEO on LinkedIn on 12/10/18—the same day that AMGN notified ADXS about the license termination:

https://ton.twitter.com/1.1/ton/data/dm/1073383458653650948/1073383449887555584/H-gUljqN.jpg:large

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up